Pilot RCT of a Chinese Medicine Diabetes Education Programme
Development and Pilot Test of a Chinese Medicine Diabetes Education Program 中醫糖尿病個人管理教育方案建構及初步試驗
The goal of this clinical trial is to learn if a Chinese medicine diabetes education programme is feasible and acceptable, and to explore its preliminary effects on self-management, for adults with type 2 diabetes in Hong Kong. The main questions it aims to answer are:
- Is the Chinese medicine diabetes education programme feasible to deliver in a community setting (recruitment, retention and adherence)?
- Is the programme acceptable to participants?
- Does the programme show early signals of improving diabetes management self-efficacy and related outcomes?
Researchers will compare the Chinese medicine education programme to usual care to see if the programme is feasible, acceptable and shows preliminary benefits.
Participants will:
- Be randomly assigned to either a 4-week Chinese medicine diabetes education programme (four group sessions, total 4-6 hours) or usual care
- Complete assessments at baseline, after the programme, and at 2-month follow-up.
- Attend a focus group interview at the end of the study (selected participants)
Outcome assessors will be blinded to group allocation.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
This pilot randomised controlled trial evaluates the feasibility, acceptability and preliminary effects of a Chinese medicine diabetes education programme for adults with type 2 diabetes in Hong Kong.
While Western-medicine-based diabetes education is well established locally, systematic and interactive Chinese medicine education remains limited. The programme integrates Chinese medicine concepts (body constitution, pattern differentiation, dietary therapy, emotional regulation, acupressure and lifestyle advice) with modern self-management principles. Content was refined through literature review, patient input and Delphi consensus.
Forty adults with type 2 diabetes will be randomly allocated (1:1) to either a 4-week group education programme (four sessions, total 4-6 hours) or usual care. The control group will be offered the programme after final follow-up. Participants and facilitators are not blinded due to the nature of the educational intervention; outcome assessors will remain blinded to group allocation.
Primary aims are to assess feasibility (recruitment, retention, adherence) and acceptability. Exploratory outcomes, measured at baseline, post-intervention and 2-month follow-up, include diabetes management self-efficacy (Chinese version of the Diabetes Management Self-Efficacy Scale, C-DMSES; Wu et al., 2008), self-management behaviours, blood glucose, lipids, BMI and blood pressure. Focus group interviews will gather qualitative feedback.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Yuen-Shan Ho, PhD
- Número de telefone: 852 2766 6410
- E-mail: janice.ys.ho@polyu.edu.hk
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Adults aged 18 years or above
- Diagnosed with type 2 diabetes mellitus
- Able to understand and communicate in Cantonese, and able to read Chinese
- Willing and able to provide written informed consent
- Able to attend the education sessions at the designated venues
Exclusion Criteria:
- Severe cognitive impairment that would prevent meaningful participation in group education
- Acute or unstable medical conditions, or serious chronic illnesses currently under active treatment (e.g., ongoing cancer treatment), that may preclude safe participation in group activities
- Currently participating in another structured diabetes education research programme
- Pregnancy
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Sem intervenção: Usual Care
Participants will continue their usual medical care and any existing diabetes education or support.
No additional structured Chinese medicine diabetes education programme will be provided during the study.
After the final follow-up, they will be offered the same education programme.
|
|
|
Experimental: Chinese Medicine Diabetes Education Programme
Participants will receive a 4-week Chinese medicine diabetes education programme consisting of four weekly group sessions (total 4-6 hours).
Content includes Chinese medicine concepts of diabetes, body constitution, diet, emotional regulation, acupressure, skin and foot care, and physical activity.
|
A structured 4-week group education programme (four sessions, total contact time 4-6 hours) that integrates Chinese medicine concepts (body constitution, pattern differentiation, dietary therapy, emotional regulation, acupressure, and lifestyle advice) with modern diabetes self-management education.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Recruitment rate
Prazo: From start of recruitment to end of recruitment period
|
Proportion of eligible individuals who provide informed consent and are randomised into the study.
|
From start of recruitment to end of recruitment period
|
|
Retention rate
Prazo: From randomisation to 2-month follow-up
|
Proportion of randomised participants who complete the post-intervention assessment (T1) and the 2-month follow-up assessment (T2).
|
From randomisation to 2-month follow-up
|
|
Adherence to the education programme
Prazo: During the 4-week intervention period
|
Proportion of participants in the intervention group who attend at least 3 out of the 4 scheduled education sessions.
|
During the 4-week intervention period
|
|
Acceptability of the programme
Prazo: At the end of the 4-week education programme
|
Participant-reported acceptability and satisfaction with the Chinese medicine diabetes education programme, assessed by a structured questionnaire at the end of the programme.
Additional qualitative feedback will be collected through focus group interviews at 2-month follow-up.
|
At the end of the 4-week education programme
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Diabetes management self-efficacy
Prazo: Baseline, post-intervention (T1), and 2-month follow-up (T2)
|
Measured by the Chinese version of the Diabetes Management Self-Efficacy Scale (C-DMSES).
|
Baseline, post-intervention (T1), and 2-month follow-up (T2)
|
|
Diabetes self-management behaviours
Prazo: Baseline, post-intervention (T1), and 2-month follow-up (T2)
|
Self-reported diabetes self-management behaviours, assessed using a participant logbook recording the frequency of exercise, acupressure, blood glucose monitoring and other self-care activities.
|
Baseline, post-intervention (T1), and 2-month follow-up (T2)
|
|
Blood glucose level
Prazo: Baseline and 2-month follow-up (T2)
|
Fasting blood glucose level, HbA1c
|
Baseline and 2-month follow-up (T2)
|
|
Blood lipid levels
Prazo: Baseline and 2-month follow-up (T2)
|
Total cholesterol, triglycerides, HDL-C and LDL-C
|
Baseline and 2-month follow-up (T2)
|
|
Body mass index (BMI)
Prazo: Baseline, post-intervention (T1), and 2-month follow-up (T2)
|
Calculated from measured height and weight.
|
Baseline, post-intervention (T1), and 2-month follow-up (T2)
|
|
Blood pressure
Prazo: Baseline, post-intervention (T1), and 2-month follow-up (T2)
|
Systolic and diastolic blood pressure.
|
Baseline, post-intervention (T1), and 2-month follow-up (T2)
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Yuen-Shan Ho, PhD, The Hong Kong Polytechnic University
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- P0046606
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .